tiprankstipranks
Trending News
More News >
Alaunos Therapeutics (TCRT)
NASDAQ:TCRT
US Market

Alaunos Therapeutics (TCRT) Financial Statements

Compare
681 Followers

Alaunos Therapeutics Financial Overview

Alaunos Therapeutics's market cap is currently $4.57M. The company's EPS TTM is $-2.922; its P/E ratio is ―; Alaunos Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 10.00K$ 5.00K$ 2.92M$ 398.00K$ 0.00
Gross Profit$ 10.00K$ -4.80M$ 163.00K$ -342.00K$ -1.13M
Operating Income$ -4.81M$ -34.27M$ -35.10M$ -77.55M$ -80.36M
EBITDA$ -4.68M$ -30.90M$ -31.82M$ -74.97M$ -78.85M
Net Income$ -4.68M$ -35.14M$ -37.60M$ -76.89M$ -78.85M
Balance Sheet
Cash & Short-Term Investments$ 1.09M$ 6.06M$ 39.06M$ 76.05M$ 115.07M
Total Assets$ 2.75M$ 8.26M$ 64.94M$ 94.86M$ 146.34M
Total Debt$ 0.00$ 0.00$ 19.51M$ 29.36M$ 4.81M
Net Debt$ -1.09M$ -6.06M$ -19.55M$ -46.69M$ -110.25M
Total Liabilities$ 692.00K$ 1.96M$ 26.38M$ 36.81M$ 22.36M
Stockholders' Equity$ 2.06M$ 6.31M$ 38.55M$ 58.06M$ 123.98M
Cash Flow
Free Cash Flow$ -4.97M$ -30.34M$ -29.45M$ -64.79M$ -66.79M
Operating Cash Flow$ -4.97M$ -30.14M$ -29.23M$ -61.47M$ -57.01M
Investing Cash Flow$ 0.00$ 1.35M$ -193.00K$ -3.32M$ -9.78M
Financing Cash Flow$ 0.00$ -18.14M$ 6.37M$ 25.78M$ 102.12M
Currency in USD

Alaunos Therapeutics Earnings and Revenue History

Alaunos Therapeutics Debt to Assets

Alaunos Therapeutics Cash Flow

Alaunos Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis